Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cancer. 2016 Oct 3;123(3):459–467. doi: 10.1002/cncr.30376

Figure 4.

Figure 4

Overall survival of adult Ph- ALL patients according to cytogenetics and MRD response at complete response. (A) Overall survival of adult Ph- ALL patients with MRD + response. (B) Overall survival of adult Ph- ALL patients with MRD – response. Poor risk cytogenetics includes MLL rearrangement, complex karyotype and low hypodiploidy/near triploidy.